Fujihara S M, Nadler S G
Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543-4000, USA.
Biochem Pharmacol. 1998 Jul 15;56(2):157-61. doi: 10.1016/s0006-2952(98)00049-5.
Eukaryotic cells depend upon the regulated exchange of proteins and RNA between the cytoplasm and the nucleus for survival. Various cytoplasmic and nuclear proteins play a fundamental role in this specific transport process. Over the last few years the components and stages of nuclear protein transport have been characterized in significant detail. Because many of the proteins that are transported into the nucleus are transcription factors, the import process is an interesting target for the manipulation of gene expression. Over time the eukaryotic cell has assembled a number of methods by which to regulate the nuclear localization of transcription factors. Within the last few years, there have been several reports of the pharmacologic manipulation of the localization of nuclear proteins as well. In addition, a recent study suggests that viruses are able to modulate host cell nuclear protein transport in vivo. This report will present an overview of nuclear protein import, describe the various in vivo mechanisms by which the cell regulates this process, and discuss recent attempts to manipulate the process with small molecule compounds. As nuclear import is a fundamental cellular process, potential opportunities for the future may arise from direct and specific ways to modulate this process and thereby treat diseases characterized by dysregulation of transcription factor activity.
真核细胞依靠细胞质与细胞核之间蛋白质和RNA的有序交换来维持生存。各种细胞质和核蛋白在这一特定运输过程中发挥着重要作用。在过去几年里,核蛋白运输的成分和阶段已得到相当详细的描述。由于许多被转运到细胞核中的蛋白质是转录因子,因此导入过程是操纵基因表达的一个有趣靶点。随着时间的推移,真核细胞已经组装了多种调节转录因子核定位的方法。在过去几年里,也有几篇关于核蛋白定位的药理学操纵的报道。此外,最近的一项研究表明,病毒能够在体内调节宿主细胞核蛋白运输。本报告将概述核蛋白导入,描述细胞在体内调节这一过程的各种机制,并讨论最近用小分子化合物操纵这一过程的尝试。由于核输入是一个基本的细胞过程,未来的潜在机会可能来自直接和特定的方式来调节这一过程,从而治疗以转录因子活性失调为特征的疾病。